Optum Infusion Services 308, LLC, Chandler, AZ
Is Optum Infusion Services 308, LLC registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Optum Infusion Services 308, LLC hold a Arizona pharmacy license?
State board of pharmacy records for Arizona are not checked: the board’s website, which hosts its license verification and board orders, answers automated requests with a bot challenge, and this index does not work around blocks. The Texas State Board of Pharmacy also lists nonresident license 36192 for OPTUM INFUSION SERVICES 308, LLC, CHANDLER, AZ, status Active, as of Nov 15, 2026. The California State Board of Pharmacy also lists nonresident license NRP 3120 for Optum Infusion Services 308 Llc, Chandler, AZ, status Active and license NSC 102019 for Optum Infusion Services 308 Llc, Chandler, AZ, status Active, as of Nov 6, 2026. The Colorado State Board of Pharmacy also lists nonresident license OSP 7952 for Optum Infusion Services 308, LLC, Chandler, AZ, status Active, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054023564 for OPTUM INFUSION SERVICES 308 LLC, CHANDLER, AZ, status ACTIVE and license 054023392 for OPTUM INFUSION SERVICES 308 LLC, CHANDLER, AZ, status CHANGE OF OWNERSHIP, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0004520 for OPTUM INFUSION SERVICES 308, LLC, CHANDLER, AZ, status ACTIVE (CURRENT), as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0013287 for Optum Infusion Services 308, LLC, CHANDLER, AZ, status Active, as of Nov 10, 2026. The Michigan Department of Licensing and Regulatory Affairs also lists nonresident license 5301013822 for Optum Infusion Services 308, LLC, Chandler, AZ, status Active, as of Nov 10, 2026.
Has Optum Infusion Services 308, LLC had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Dec 13, 2022) for Optum Infusion Services 308, LLC. State board of pharmacy records for Arizona are not checked: the board’s website, which hosts its license verification and board orders, answers automated requests with a bot challenge, and this index does not work around blocks.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Optum Infusion Services 308, LLC
- Location
- Chandler, AZ
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- Dec 13, 2022
- FDA Data Dashboard inspections
- No matching site found
- Form 483 text on this page
- 1 Form 483, 6 observations
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Optum Infusion Services 308, LLC, a 503A facility, with 2 dated actions.
| Document | |||
|---|---|---|---|
| Dec 13, 2022 | Warning letter | Warning Letter Issued 12/13/2022 | FDA copy (archived) |
| Mar 18, 2022 | Form 483 | 483 issued 3/18/2022 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own.
FDA inspection classifications and published Form 483s
No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 6 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Mar 8, 2022 to Mar 18, 2022: 6 observations
- Firm on the cover
- Optum Infusion Services 308, LLC, 2555 W Fairview St Ste 104 Bldg D, Chandler, AZ 85224 -4708
- FEI number
- 3017600845
- Establishment type on the cover
- Producer of Sterile Drug Products
- FDA district office on the cover
- 19701 Fairchild Irvine, CA 92612-2445
- Matched to this page by
- firm name, city and state on the cover; linked from actions page
- FDA document
- Read the full 483 (Internet Archive copy FDA links)
Observation 1
You did not make adequate product evaluation and take remedial action where actionable microbial contamination was found to be present in the ISO 5 classified aseptic processing area during aseptic production.
Specifically, your firm failed to evaluate the potential impact of sterile drug products produced in your cleanroom after positive microbiological growth (bacterial/fungal growth) was found in ISO-5 hoods.
A. EM/Microbiological growth excursion dated November 22, 2021: On 11/22/2021, your firm conducted <Redacted B4> environmental monitoring in ISO-5, ISO7, & ISO-8 areas and collected viable air and contact surface samples for testing. The EM samples were incubated, and growth (contact surface) was <Redacted B4> recovered from the keypad of a Repeater Pump <Redacted B4> located inside the ISO-5 (Hood <Redacted B4> ) and <Redacted B4> in IS0-7 <Redacted B4> room. The positive plates were shipped to <Redacted B4> for ID test and on 12/3/2021 you were informed the identity of the organisms were Brevivacterium species, Micrococcus species, and Coagulase Negative Staphylococcus. ...
Observation 2
Personnel touched equipment or other surfaces located outside of the ISO 5 classified aseptic processing area with gloved hands and then engaged in aseptic processing without changing or sanitizing gloves.
Specifically,
A. On 3/8/2022, a compounding technician was observed opening sterile bags <Redacted B4> in ISO-7 <Redacted B4> area then moving the bags into ISO-5 Laminar Air Flow Hood (Hood <Redacted B4> to make Rx# <Redacted B4> SMOFlipid 20% 500ml bag). The same technician was observed not sanitizing the gloved hands in ISO-7 environment before touching the DCA (Direct Compounding Area) inside the ISO-5 hood.
B. On 3/ 10/ 2022, two technicians were observed with hair not fully covered (hair sticking out on back of head) while they were performing <Redacted B4> cleaning in the ISO-7 <Redacted B4> room and ISO-5 hoods.
C. On 12/ 13/ 2021, video of <Redacted B4> cleaning was reviewed and I observed personnel storing sterile supplies (ex: sterile bags, tubes, syringes) in trash bags then placing the entire content of the trash bags (sterile supplies+ trash bags) into cleanroom trash bins. Sterile supplies are used to make drug sterile products in ISO-5 hoods.
D. ...
Observation 3
Personnel engaged in aseptic processing were observed with exposed hair.
Specifically, on 3/11/2022, two technicians were observed with facial hair (beard) protruding out of their masks while producing sterile drug products. One technician was observed standing in front of the ISO-5 Hood <Redacted B4> while producing Rx# <Redacted B4> (CeFAZolin 2gm in 20ml). The other technician was observed standing in front of the ISO-5 Hood <Redacted B4> while producing <Redacted B4> . Both sterile prescriptions listed above were released and distributed to patients.
Observation 4
The ISO 5 classified aseptic processing areas had particle-generating equipment or surface.
Specifically, your firm conducted <Redacted B4> certification of classified areas (ISO 5, ISO-7, & ISO 8) including smoke studies then resumed sterile operations on the same day without cleaning. Video recording shows static and dynamic smoke studies were performed on all ISO-5 hoods (hood <Redacted B4>), Video recording also revealed actual drug products were used in dynamic smoke study for hood <Redacted B4>. Your firm failed to provide evidence showing that cleanroom areas and ISO-5 hoods were cleaned and disinfect after the certification process and smoke studies done on 4/16/2021. Prescription log shows that over sterile drug products were made and released for distribution to patients on 4/16/2021.
Observation 5
Vennin was observed in your production area.
Specifically, your firm failed to implement effective remediation plan and pest control program resulting in three incidents of pest/insects found in the classified areas (ISO-5, ISO-7, ISO-8) where sterile drug products are made:
• One live gnat landed inside of ISO-5 Laminar Air Flow Hood <Redacted B4> on 4/2/2021. Your firm failed to evaluate the potential impact to sterile drug products made in Hood <Redacted B4> on 4/2/2021.
• One live crane fly found in <Redacted B4> room (ISO-7) on 3/10/2021. • One live fly found in the exit <Redacted B4> room (ISO-8) on 2/7/2022.
Observation 6
You had inadequate HEPA filter airflow over the area to which sterile product was exposed.
Specifically, the smoke study conducted under dynamic conditions for ISO-5 hoods (hoods <Redacted B4>, <Redacted B4> performed on April 16, 2021 does not represent your actual work conditions of making sterile drug products and did not show the various techniques or equipment set in normal operations. For example the sterile drug production of TPN (Total Parenteral Nutrient) products using the Repeater Pump and <Redacted B4> equipment/machines.
State board of pharmacy records
State board of pharmacy records for Arizona are not checked: the board’s website, which hosts its license verification and board orders, answers automated requests with a bot challenge, and this index does not work around blocks.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Texas State Board of Pharmacy, file dated Nov 15, 2026 (Texas).
| License | Type as the board gives it | Name on the board record | Location | Status | Prior disciplinary orders (file flag) |
|---|---|---|---|---|---|
| 36192 | Non Resident Sterile Compounding | OPTUM INFUSION SERVICES 308, LLC | CHANDLER, AZ | Active | No |
California State Board of Pharmacy, file dated Nov 6, 2026 (California).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| NRP 3120 | Non Resident Pharmacy | Optum Infusion Services 308 Llc | Chandler, AZ | Active |
| NSC 102019 | Non Resident Licensed Sterile Compounding | Optum Infusion Services 308 Llc | Chandler, AZ | Active |
Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| OSP 7952 | OSP | Optum Infusion Services 308, LLC | Chandler, AZ | Active |
Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 054023564 | LICENSED PHARMACY | OPTUM INFUSION SERVICES 308 LLC | CHANDLER, AZ | ACTIVE |
| 054023392 | LICENSED PHARMACY | OPTUM INFUSION SERVICES 308 LLC | CHANDLER, AZ | CHANGE OF OWNERSHIP |
Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| PCN.0004520 | NONRESIDENT PHARMACY | OPTUM INFUSION SERVICES 308, LLC | CHANDLER, AZ | ACTIVE (CURRENT) |
Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| A9-0013287 | Non Resident Pharmacy | Optum Infusion Services 308, LLC | CHANDLER, AZ | Active |
Michigan Department of Licensing and Regulatory Affairs, file dated Nov 10, 2026 (Michigan).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 5301013822 | Pharmacy | Optum Infusion Services 308, LLC | Chandler, AZ | Active |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Texas State Board of Pharmacy license file
- California State Board of Pharmacy license file
- Colorado State Board of Pharmacy license file
- Illinois Department of Financial and Professional Regulation license file
- Connecticut Department of Consumer Protection license file
- Delaware Division of Professional Regulation license file
- Michigan Department of Licensing and Regulatory Affairs license file
- Texas State Board of Pharmacy disciplinary records
- California State Board of Pharmacy disciplinary records
- Delaware Division of Professional Regulation disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.